{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["26(16)"],"submitter":["Funk T"],"pubmed_abstract":["We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0-2.9; B.1.351: 3.6, 95% CI: 2.1-6.2; P.1: 2.6, 95% CI: 1.4-4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4-3.5; P.1: 2.2, 95% CI: 1.7-2.8)."],"journal":["Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8063589"],"repository":["biostudies-literature"],"pubmed_title":["Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021."],"pmcid":["PMC8063589"],"pubmed_authors":["Mossong J","Borges V","Spiteri G","O'Connor L","Suija H","Blomqvist S","Savolainen-Kopra C","Isidro J","Carr M","Pharris A","Helve O","Lo Presti A","Murphy N","Ferreira R","Garcia-Leon A","Stefanelli P","Di Martino A","Epstein J","Dotsenko L","Ikonen N","Adlhoch C","Abdelrahman T","COVID study groups","Bella A","Vergison A","Riccardo F","Gomes-Dias J","Crispie F","Gonzalez G","Wienecke-Baldacchino AK","Funk T","Casaca P","Gomes JP","Melidou A","Moreno J","Sadikova O","Mottonen T","Sepp H","Bundle N"],"additional_accession":[]},"is_claimable":false,"name":"Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021.","description":"We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0-2.9; B.1.351: 3.6, 95% CI: 2.1-6.2; P.1: 2.6, 95% CI: 1.4-4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4-3.5; P.1: 2.2, 95% CI: 1.7-2.8).","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Apr","modification":"2026-05-08T06:07:54.175Z","creation":"2022-02-09T16:08:04.849Z"},"accession":"S-EPMC8063589","cross_references":{"pubmed":["33890566"],"doi":["10.2807/1560-7917.ES.2021.26.16.2100348"]}}